Susan Schneider - 21 Aug 2022 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGTC	Stock Option (right to buy)	Award	$0	+142,300		$0.000000	142,300	21 Aug 2022	Common Stock	142,300	$0.4000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option becomes exercisable in equal monthly installments over four years from the date of grant.